ImmuneBridge is developing allogeneic immunotherapies for cancer. ImmuneBridge's key innovation fosters the development of immune stem cells obtained from cord blood and creates a fresh, adaptable, reliable, and plentiful cellular source for immunotherapies. They are currently looking for natural killer cell-based treatments for hematologicalcancers. They will then attack solid tumors using the special benefits of their cellular source.

Biotechnology

Health Care

Information Technology

ImmuneBridge

This department focuses on software development and data management to drive innovation and optimize operations.

Software and Data

This department oversees corporate governance practices and provides guidance on board operations and member responsibilities.

Board Governance

This department oversees the strategic direction and innovation of scientific initiatives within the organization.

People (2)

Jobs (0)

Other teams

Board Governance

Scientific Leadership